Professor Saltzman uses cancer diagnosis and treatment as an example to demonstrate the some applications of biomedical engineering technologies and methods. Some issues involved in cancer treatment, such as tumor angiogenesis, radiation sensitivity, drug localization, and cancer stem cells are mentioned. Next, he describes the phases (I-IV), in compliance to guidelines enforced by the Food and Drug Administration (FDA), which a new drug compound must go through to gain approval prior to public distribution/sale. Finally, Professor Saltzman draws attention to the areas that biomedical engineers may contribute to, to improve this process.
The course covers basic concepts of biomedical engineering and their connection with the spectrum of human activity. It serves as an introduction to the fundamental science and engineering on which biomedical engineering is based. Case studies of drugs and medical products illustrate the product development-product testing cycle, patent protection, and FDA approval. It is designed for science and non-science majors.